Bristol-Myers Squibb Co.

Pharmaceuticals
United States
2016 Revenue (US$ Millions)$19,427
Revenue Growth (%)17.31%
Net Income (US$ Millions)$4,457
Earnings Per Share (US$)$2.65
EPS Growth Rate (%)184.95%
Profit Margin22.94%
Total Equity (US$ Millions)$16,177
Return on Equity (%)31.24%
Long Term Debt (US$ Millions)$5,716
Debt To Equity Ratio (%)0.35%
Total Assets (US$ Millions)$33,707
Current Assets (US$ Millions)$13,704
Current Liabilities (US$ Millions)$8,841
Cost of Goods Sold (US$ Millions)$4,946
Inventory Turnover4.02